• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

UC2288

CAS No. 1394011-91-6

UC2288 ( —— )

产品货号. M28840 CAS No. 1394011-91-6

UC2288是一种相对选择性的p21衰减剂,是在索拉非尼的基础上合成的。 UC2288 降低 p21 蛋白水平,对 p21 蛋白稳定性影响极小。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥786 有现货
10MG ¥1191 有现货
25MG ¥2236 有现货
50MG ¥3345 有现货
100MG ¥4155 有现货
200MG ¥5176 有现货
500MG ¥7517 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    UC2288
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    UC2288是一种相对选择性的p21衰减剂,是在索拉非尼的基础上合成的。 UC2288 降低 p21 蛋白水平,对 p21 蛋白稳定性影响极小。
  • 产品描述
    UC2288 is a relatively selective p21 attenuator which is synthesized based Sorafenib. UC2288 attenuates p21 protein levels with minimal effect on p21 protein stability.(In Vitro):UC2288 (0-10 μM; 24 hours) decreases p21 mRNA expression transcriptionally or post-transcriptionally but independently of p53. UC2288 has no inhibition of VEGFR2 and Raf kinases even at 10 μM.(In Vivo):UC2288 (10 mg/kg; i.p.) attenuates MPTP-induced behavioral impairment, prevents activation of MAPK pathway in the MPTP-treated mice brain. MPTP treatment raises TNF-α, IL-6 and IL-1β levels in MPTP treated mice brain, but UC2288 signicantly decreases MPTP-induced TNF-α, IL-6 levels, but IL-1β is not decreased in brain.UC2888 (15 mg/kg; oral) co-treatment with imetelstat significantly suppresses tumor growth and does not effect mice weight.
  • 体外实验
    Western Blot Analysis Cell Line:HK2 (normal kidney), 786-O (RCC), Caki-1 (RCC), ACHN (RCC) and HEY (ovarian cancer) cells Concentration:0 μM; 1 μM; 3 μM; 10 μM Incubation Time:24 hours Result:Decreased p21 protein expression. RT-PCR Cell Line:p53-mutant?RCC cell line 786-O Concentration:10 μM Incubation Time:24 hours Result:Decreased p21 mRNA independent of p53 expression.
  • 体内实验
    Animal Model:Eight-week old, athymic nude (NCr nu/nu) mice injected subcutaneously with HCT116 and ACHN cancer cells(2.5x106) Dosage:15 mg/kg Administration:Oral gavage; 3 times a week; 4 weeks; co-treatment with imetelstat Result:Combined treatment with imetelstat synergistically inhibited tumor growth in mice.Animal Model:MPTP-induced C57BL6 Parkinson’s disease mice model Dosage:10 mg/kg Administration: Intraperitoneal? injection; 4 times in 7 days Result:Ameliorated MPTP induced PD progression through inhibition of neuroinammation.
  • 同义词
    ——
  • 通路
    Apoptosis
  • 靶点
    MDM2-p53
  • 受体
    mGluR4
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    1394011-91-6
  • 分子量
    481.82
  • 分子式
    C20H18ClF6N3O2
  • 纯度
    >98% (HPLC)
  • 溶解度
    In Vitro:?DMSO : 50 mg/mL (103.77 mM)
  • SMILES
    FC(F)(F)c1ccc(O[C@H]2CC[C@@H](CC2)NC(=O)Nc2ccc(Cl)c(c2)C(F)(F)F)nc1
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Niswender CM, et al. Discovery, characterization, and antiparkinsonian effect of novel positiveallosteric modulators of metabotropic glutamate receptor 4. Mol Pharmacol. 2008 Nov;74(5):1345-58.
产品手册
关联产品
  • MMRi64

    MMRi64 是一种小分子抑制剂,可在体外破坏 Mdm2-MdmX RING-RING 相互作用并激活癌细胞中的 p53。

  • MI 219

    MI 219 是一种有效的特异性 MDM2-p53 抑制剂,Ki 为 5 nM,对 MDM2 的选择性是 MDMX 的 10,000 倍以上。

  • Nutlin-3b

    一种 p53/MDM2 拮抗剂或抑制剂,IC50 值为 13.6 μM。